COMP <GO>
SOLS vs ALB // REVENUE GROWTH (YOY)
Solstice Advanced Materials Inc. (NASDAQ) VS. Albemarle Corporation (NYSE) • 15-METRIC TALLY: SOLS 8
— ALB 4
▲ REVENUE GROWTH (YOY) LEADER: SOLS
LAST: $60.55 (-3.21%) • MKT CAP: $9.94B
revenue-growth
3.10%
LAST: $91.00 (-2.43%) • MKT CAP: $11.01B
revenue-growth
-4.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SOLS VS. ALB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SOLS | ALB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.20% | 13.00% | +19.20 | SOLS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.00% | -2.60% | +10.60 | SOLS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.20% | 6.29% | -5.09 | ALB | /fcf-yield <GO> |
| Operating Margin | 7.40% | -7.10% | +14.50 | SOLS | /operating-margins <GO> |
| Net Profit Margin | 6.10% | -9.90% | +16.00 | SOLS | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 3.10% | -4.40% | +7.50 | SOLS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 11.50% | 1.73% | +9.77 | SOLS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.39 | 1.64 | +0.75 | SOLS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | ALB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.0 | 37.3 | +17.70 | SOLS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.01 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.0x | 20.0x | +19.00 | ALB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.94B | $11.01B | -$1.07B | ALB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SOLS REV | ALB REV | SOLS GROSS % | ALB GROSS % | SOLS FCF | ALB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.89B | $5.14B | 32.2% | 13.0% | $119.0M | $692.5M |
| FY 2024 | $3.77B | $5.38B | 34.6% | 1.2% | $546.0M | -$992.7M |
| FY 2023 | $3.65B | $9.62B | — | — | $595.8M | $893.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SOLS // BETA 1.01
ALB // BETA 1.01